Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model

Author(s): Sarah B. Martin, Amy L.S. Dowling, Elizabeth Head

Journal Name: Current Neuropharmacology

Volume 9 , Issue 4 , 2011

Become EABM
Become Reviewer
Call for Editor


Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A

Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [651 - 661]
Pages: 11
DOI: 10.2174/157015911798376217
Price: $65

Article Metrics

PDF: 3